STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
INCY INCYTE CORPORATION StockScouter® Report
7
StockScouter® Score
INCYTE CORPORATION, a mid cap growth company in the healthcare sector, is expected to outperform the market over the next six months with less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The enterprise value-to-sales ratio is lower than the average for comparably-sized companies in the StockScouter universe. Positive
- The ratio of INCY’s forward price-to-earnings multiple to its estimated growth rate is well below the average of comparably-sized companies in the StockScouter universe. Positive
Concerns
- The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative
- Short-term relative price momentum exhibits meaningful weakness. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
B
C
B
C